<DOC>
	<DOC>NCT00282646</DOC>
	<brief_summary>Patients with peripheral artery disease, stage III or IV who are not candidates for interventional or operative therapy should be treated with intraarterial progenitor cell therapy (autologous bone marrow cells) in a randomized, placebo controlled trial.</brief_summary>
	<brief_title>Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)</brief_title>
	<detailed_description>Main goal: Improvement of limb perfusion (Ankle brachial index). Secondary aims: Reduction of pain Reduction of Ulcer size Walking distance Improvement in tissue oxygenation (TCO2) Minor or major amputation</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Patients with PAOD (Stage III or IV) Distal arterial occlusions Patients with Buergers Disease Signed informed consent Successful bypass operation or intervention within the last 3 months Active infection, feber, chronic inflammatory disease HIV, Hepatitis Tumor within the last 5 years, complete remission required Stroke or myocardial infarction within last 3 months Renal insufficiency (creatinine &gt; 2 mg/dl) Liver disease (GOT &gt; 2x upper limit oder spontaneous INR &gt; 1,5). Anemia (hemoglobin &lt; &lt;10 mg/dl) Thrombocytopenia &lt; 100.000/Âµl Allergies to Aspirin, Clopidogrel, Heparin Bleeding disorder Gastrointestinal bleeding within last 3 months Surgery or trauma within the last 2 months Pregnancy Mental retardation Inclusion in other clinical study within last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>peripheral arterial occlusive disease</keyword>
	<keyword>[C14.907.137]</keyword>
</DOC>